New Report Explores on Global Asthma Therapeutics Market 2016-2020

Global Asthma Therapeutics Market 2016-2020 is a new market research publication announced by Reportstack. Increasing allergic rhinitis is a major factor for allergic asthma leading to increase in research for the development of allergic immunotherapies for the treatment of asthma. The global asthma therapeutics market will observe a moderate growth during the forecast period because of loss of patent exclusivity of the major drugs, allowing the entry of generics into the market. This will lead to the erosion of the market share of the major asthma drugs. However, the presence of late-stage pipeline molecules will drive the market. An increase in the prevalence of asthma and the use of combination drugs will drive the growth of the market during the forecast period.

The analysts forecast the global asthma therapeutics market to grow at a CAGR of 4.31% during the period 2016-2020.

To access full report with TOC, please visit Global Asthma Therapeutics Market 2016-2020

The report covers the present scenario and the growth prospects of the global asthma therapeutics market for 2016-2020. To calculate the market size, The report considers the revenue generated from the sales of brand-name, generic, and off-label drugs used for the prevention and treatment of asthma. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from patent expiries of marketed drugs during the forecast period.

The market is divided into the following segments based on geography: 
• Americas

Key vendors 

• AstraZeneca
• Boehringer Ingelheim
• F. Hoffmann-La Roche
• Merck 
Other prominent vendors 
• ALK-Abello
• Amgen
• Array BioPharma
• Asmacure
• Astellas Pharma
• Atopix Therapeutics
• Axikin Pharmaceuticals
• Chiesi Farmaceutici
• Dynavax Technologies Corp.
• Horizon Pharma
• Hovione Scientia
• Invion
• Ivax
• Kissei Pharmaceutical
• Kyowa Hakko Kirin
• MediciNova
• Mitsubishi Tanabe Pharma Corporation
• Mundipharma
• Nycomed
• Oxagen Limited
• Palobiofarma
• Pearl Therapeutics
• Pharmaking
• Pharmaxis
• Pulmagen Therapeutics
• Regeneron Pharmaceuticals
• Revalesio 
• RSPR Pharma AB
• SAMA Pharmaceuticals
• Sanofi
• Skyepharma
• SolAeroMed
• Stallergenes
• Sterna Biologicals
• Synairgen
• Theron Pharmaceuticals
• UCB Pharma
• Vectura
• Verona Pharma
• Whanin Pharmaceutical Company

Companies Mentioned

AstraZeneca, Boehringer Ingelheim, F. Hoffmann-La Roche, GSK, Merck, ALK-Abello, Amgen, Array BioPharma, Asmacure, Astellas Pharma, Axikin Pharmaceuticals, Chiesi Farmaceutici, Dynavax Technologies, Horizon Pharma, Hovione Scientia, Invion, Ivax, Kissei Pharmaceutical, Kyowa Hakko Kirin, MediciNova, Mitsubishi Tanabe Pharma, Mundipharma, Nycomed, Oxagen Limited, Palobiofarma, Pearl Therapeutics, Pharmaking, Pharmaxis, Pulmagen Therapeutics, Regeneron Pharmaceuticals, Revalesio, RSPR Pharma AB, SAMA Pharmaceuticals, Sanofi, Skyepharma, SolAeroMed, Stallergenes, Sterna Biologicals, Synairgen, Theron Pharmaceuticals, UCB Pharma, Vectura, Verona Pharma, Whanin Pharmaceutical.


Debora White

Manager - Marketing

Ph: +1-888-789-6604

Reportstack Market Research